HIV drug Aptivus gains new indication approval for kids

Article

Boehringer Ingelheim's Aptivus can now be used to treat HIV-infected pediatric patients.

Pediatric patients between two and 18 years of age who are infected with HIV have a new treatment available to them. It’s Boehringer Ingelheim Pharmaceuticals’

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.